Motivation to Quit Using Substances Among Individuals With Schizophrenia: Implications for a Motivation-based Treatment Model
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Although the motivation to quit using substances is an important prognostic and treatment-matching factor in substance abuse treatment, there is limited information on motivation to quit among individuals with schizophrenia. This study used the five-stages-of-change model to evaluate the motivational levels of 497 individuals with schizophrenia or schizoaffective disorder in an outpatient mental health clinic. Rates of substance abuse, motivation levels to quit each specific substance, and correlates to motivational levels were evaluated. At least one substance use disorder was diagnosed in 224 of the subjects (45%); however, there was significant variability among the caseloads of the outpatient division teams. The patients in the triage/acute services and community outreach teams had substance abuse rates of about 70 percent. Most subjects had low motivation to quit substances, and the rates varied according to substance (range of 41% for opiates to 60% for cocaine). Treatment-matching strategies are suggested in the motivation-based treatment model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Stages and processes of self-change of smoking: Toward an integrative model of change.
Prochaska, J. O., & DiClemente, C. C. (1983) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.51.3.390 · Cited by 9,098
In search of how people change: Applications to addictive behaviors.
Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992) · American Psychologist · doi:10.1037/0003-066x.47.9.1102 · Cited by 8,596
(1991) · Medical Entomology and Zoology · Cited by 4,438
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Stages of change and decisional balance for 12 problem behaviors.
Prochaska, J. O., Velicer, W. F., Rossi, J. S., Goldstein, M. G., Marcus, B. H., Rakowski, W., Fiore, C., Harlow, L. L., Redding, C. A., Rosenbloom, D., et al. (1994) · Health Psychology · doi:10.1037//0278-6133.13.1.39 · Cited by 2,469
DISEASES OF THE NERVOUS SYSTEM
JELLIFFE, S. E., & WHITE, W. A. (1918) · The American Journal of the Medical Sciences · doi:10.1097/00000441-191803000-00015 · Cited by 1,277
Motivation for treatment: A review with special emphasis on alcoholism.
Miller, W. R. (1985) · Psychological Bulletin · doi:10.1037//0033-2909.98.1.84 · Cited by 620
Prevalence of Substance Abuse in Schizophrenia: Demographic and Clinical Correlates
Mueser, K. T., Yarnold, P. R., Levinson, D. F., Singh, H., Bellack, A. S., Kee, K., Morisson, R. L., & Yadalam, K. G. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.1.31 · Cited by 587
Drug abuse in schizophrenic patients: clinical correlates and reasons for use
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.2.224 · Cited by 547 · cited 1×
“The highest rates of dual diagnosis are reported in emergency room, triage, inpatient, and outreach teams (Galanter et al. 1988; Dixon et al. 1991; Selzer and Liebenman 1993).”
Background
Cited by
Implementing Dual Diagnosis Services for Clients With Severe Mental Illness
Drake, R. E., Essock, S. M., Shaner, A., Carey, K. B., Minkoff, K., Kola, L., Lynde, D., Osher, F. C., Clark, R. E., & Rickards, L. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.4.469 · Cited by 693
Hunt, G. E., Large, M. M., Cleary, M., Lai, H. M. X., & Saunders, J. B. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.011 · Cited by 482
Drake, R. E., Mueser, K. T., Brunette, M. F., & McHugo, G. J. (2004) · Psychiatric Rehabilitation Journal · doi:10.2975/27.2004.360.374 · Cited by 459
Drake, R. E., O'Neal, E. L., & Wallach, M. A. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.01.011 · Cited by 447
“Models identifying stages of treatment and stages of change are clinically relevant because different interventions are effective at different stages of the recovery process (Carey, 1996; Osher & Kofoed, 1989; McGovern, Wrisley, & Drake 2005; Ziedonis & Trudeau, 1997).”
BackgroundGeorge, T. P., Ziedonis, D. M., Feingold, A., Pepper, W. T., Satterburg, C. A., Winkel, J., Rounsaville, B. J., & Kosten, T. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1835 · Cited by 354
Self-citationLittell, J. H., & Girvin, H. (2002) · Behavior Modification · doi:10.1177/0145445502026002006 · Cited by 333
“…dual diagnosis program Willoughby and Edens (1996) 144 inpatient substance abusers URICA (32 items) PC, C, A, M; two (male veterans) clusters (PC, C/A) Ziedonis and Trudeau (1997) 497 adults with schizophrenia or Five-question stage-of-change algorithm adapted PC, C, P, A, M schizoaffective…”
BackgroundCo-Occurring Severe Mental Illness and Substance Use Disorders: A Review of Recent Research
RachBeisel, J., Scott, J., & Dixon, L. (1999) · Psychiatric Services · doi:10.1176/ps.50.11.1427 · Cited by 331
Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis
Koskinen, J., Lohonen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp031 · Cited by 320
Psychosocial Approaches to Dual Diagnosis
Drake, R. E., & Mueser, K. T. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033429 · Cited by 305
Motivational Interviewing and Treatment Adherence among Psychiatric and Dually Diagnosed Patients
SWANSON, A. J., PANTALON, M. V., & COHEN, K. R. (1999) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199910000-00007 · Cited by 298
A placebo controlled trial of bupropion for smoking cessation in schizophrenia
George, T. P., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. J., & Kosten, T. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01339-2 · Cited by 292
Bellack, A. S., Bennett, M. E., Gearon, J. S., Brown, C. H., & Yang, Y. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.426 · Cited by 285
Testing hypotheses about the relationship between cannabis use and psychosis
Degenhardt, L., Hall, W., & Lynskey, M. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00064-4 · Cited by 270
Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden
Cantor-Graae, E., Nordström, L. G., & McNeil, T. F. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00114-6 · Cited by 261
Cannabis use predicts future psychotic symptoms, and vice versa
Ferdinand, R. F., Sondeijker, F., Van Der Ende, J., Selten, J., Huizink, A., & Verhulst, F. C. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01070.x · Cited by 212
“Although the association between cannabis use and psychosis has been documented for clinical samples ( Ziedonis & Trudeau 1997; Fowler et al. 1998), general population samples (Regier et al. 1990; Kessler et al. 1997; Degenhardt & Hall 2001) and samples of incarcerated individuals (Farrell et al. 2002; Vreugdenhil et…”
BackgroundEvins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110073920 · Cited by 191
“However, systematic inquiry into smoking cessation strategies for people with schizophrenia has been limited (Dalack & Meador- Woodruff, 1999; Hartman, Leong, Glynn, Wilkins, & Jarvik, 1991; Ziedonis & George, 1997).”
Critical Time Intervention for Reentry From Prison for Persons With Mental Illness
Draine, J., & Herman, D. B. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.12.1577 · Cited by 184
Martino, S., Carroll, K. M., Nich, C., & Rounsaville, B. J. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01554.x · Cited by 97
Metadata
- Authors
- Ziedonis, D. M., & Trudeau, K.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-01-01
- Volume
- 23
- Issue
- 2
- Pages
- 229-238
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W1971730610
- Cited by
- 162
- References
- 31
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.